×
About 190 results

ALLMedicine™ Coronary Drug-eluting Stent Center

Research & Reviews  91 results

Ultrathin biodegradable polymer sirolimus-eluting stent versus contemporary durable pol...
https://doi.org/10.1097/MCA.0000000000000949
Coronary Artery Disease; Sethi A, Kodumuri V et. al.

Sep 8th, 2020 - Improvements in coronary drug-eluting stent technology has focused on reducing the long-term complications associated with the effects of the residual footprint on the vessel wall. Although many of the newer stents have exhibited noninferiority to...

Use of artificial intelligence as innovative method for liver graft macrosteatosis asse...
https://doi.org/10.1002/lt.25801
Liver Transplantation : Official Publication of the Ameri... Cesaretti M, Brustia R et. al.

May 18th, 2020 - We sought to compare in-hospital outcomes between patients with and without end-stage renal disease (ESRD) undergoing coronary drug-eluting stent (DES) placement and to model risk of in-hospital adverse postpercutaneous coronary intervention (PCI)...

End-stage renal disease as an independent risk factor for in-hospital mortality after c...
https://doi.org/10.1002/ccd.28929
Catheterization and Cardiovascular Interventions : Offici... Dunn AN, Huded C et. al.

May 18th, 2020 - We sought to compare in-hospital outcomes between patients with and without end-stage renal disease (ESRD) undergoing coronary drug-eluting stent (DES) placement and to model risk of in-hospital adverse postpercutaneous coronary intervention (PCI)...

Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purul...
https://doi.org/10.1016/j.cjca.2020.01.007
The Canadian Journal of Cardiology; Riku S, Suzuki S et. al.

May 14th, 2020 - Coronary stent infection is considered to be a rare but catastrophic complication of percutaneous coronary intervention. In this report, we present a 72-year-old man who developed a coronary stent infection complicated by coronary aneurysm and pur...

Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting St...
https://doi.org/10.1055/s-0040-1709520
Thrombosis and Haemostasis; Dai C, Chen Z et. al.

May 5th, 2020 - Cilostazol-based dual antiplatelet therapy (DAPT) is widely used in patients with aspirin intolerance after coronary drug-eluting stent (DES) implantation in China. However, this empirical strategy is not recommended or even mentioned in Chinese o...

see more →

Guidelines  1 results

Quality Improvement Guidelines for Mesenteric Angioplasty and Stent Placement for the Treatm...
https://www.jvir.org/article/S1051-0443(17)31070-9/fulltext
Pillai, A.,et al.

Apr 30th, 2018 - The membership of the Society of Interventional Radiology (SIR) Standards of Practice Committee represents experts in a broad spectrum of interventional procedures from the private and academic sectors of medicine. Generally, Standards of Practice.

see more →

Clinicaltrials.gov  95 results

Ultrathin biodegradable polymer sirolimus-eluting stent versus contemporary durable pol...
https://doi.org/10.1097/MCA.0000000000000949
Coronary Artery Disease; Sethi A, Kodumuri V et. al.

Sep 8th, 2020 - Improvements in coronary drug-eluting stent technology has focused on reducing the long-term complications associated with the effects of the residual footprint on the vessel wall. Although many of the newer stents have exhibited noninferiority to...

Use of artificial intelligence as innovative method for liver graft macrosteatosis asse...
https://doi.org/10.1002/lt.25801
Liver Transplantation : Official Publication of the Ameri... Cesaretti M, Brustia R et. al.

May 18th, 2020 - We sought to compare in-hospital outcomes between patients with and without end-stage renal disease (ESRD) undergoing coronary drug-eluting stent (DES) placement and to model risk of in-hospital adverse postpercutaneous coronary intervention (PCI)...

End-stage renal disease as an independent risk factor for in-hospital mortality after c...
https://doi.org/10.1002/ccd.28929
Catheterization and Cardiovascular Interventions : Offici... Dunn AN, Huded C et. al.

May 18th, 2020 - We sought to compare in-hospital outcomes between patients with and without end-stage renal disease (ESRD) undergoing coronary drug-eluting stent (DES) placement and to model risk of in-hospital adverse postpercutaneous coronary intervention (PCI)...

Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purul...
https://doi.org/10.1016/j.cjca.2020.01.007
The Canadian Journal of Cardiology; Riku S, Suzuki S et. al.

May 14th, 2020 - Coronary stent infection is considered to be a rare but catastrophic complication of percutaneous coronary intervention. In this report, we present a 72-year-old man who developed a coronary stent infection complicated by coronary aneurysm and pur...

Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting St...
https://doi.org/10.1055/s-0040-1709520
Thrombosis and Haemostasis; Dai C, Chen Z et. al.

May 5th, 2020 - Cilostazol-based dual antiplatelet therapy (DAPT) is widely used in patients with aspirin intolerance after coronary drug-eluting stent (DES) implantation in China. However, this empirical strategy is not recommended or even mentioned in Chinese o...

see more →

News  3 results

BIOFLOW V: Orsiro outperforms Xience stent
https://www.mdedge.com/cardiology/article/178950/interventional-cardiology-surgery/bioflow-v-orsiro-outperforms-xience
Susan London

Nov 5th, 2018 - SAN DIEGO – Seemingly nuanced differences between drug-eluting stents can translate to substantial differences in clinical outcomes longer term, updated results of the BIOFLOW V randomized trial reported at the Transcatheter Cardiovascular Therape.

Reigning Coronary DES King Matches Its Predecessor
https://www.mdedge.com/internalmedicine/article/37228/cardiology/reigning-coronary-des-king-matches-its-predecessor
Mitchel L. Zoler

Aug 30th, 2011 - PARIS – The current master of the coronary drug-eluting stent universe, the everolimus-eluting stent, finally proved itself fully worthy of its position, matching the efficacy and safety performance of its predecessor, the sirolimus-eluting corona.

Coronary Drug-Eluting Stent Safety Diminishes Over Time
https://www.medpagetoday.com/cardiology/pci/12228

Dec 18th, 2008 - Action Points Explain to interested patients that this study suggests that both drug-eluting and bare-metal stents have good long-term safety profiles. Explain to patients who ask that a number of factors influence the choice of stent type. Explai...

see more →